Abiopharma

🔍 HANISH ARNOLD C (Executive)

Company: Decoy Therapeutics Inc. (DCOY)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 3,000 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: A | equity_swap_involved: false | shares_owned_after: 3,418.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan, 100 percent will vest on August 30, 2027.
• F2: Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock split effective on March 6, 2026.